Cytokine-regulated expression of survivin in myeloid leukemia
- PMID: 11313272
- DOI: 10.1182/blood.v97.9.2784
Cytokine-regulated expression of survivin in myeloid leukemia
Abstract
Survivin, a member of the inhibitors-of-apoptosis gene family, is expressed in a cell-cycle-dependent manner in all the most common cancers but not in normal differentiated adult tissues. Survivin expression and regulation were examined in acute myeloid leukemia (AML). Survivin was detected by Western blot analysis in all myeloid leukemia cell lines and in 16 of 18 primary AML samples tested. In contrast, normal CD34(+) cells and normal peripheral blood mononuclear cells expressed no or very low levels of survivin. Cytokine stimulation increased survivin expression in leukemic cell lines and in primary AML samples. In cultured primary samples, single-cytokine stimulation substantially increased survivin expression in comparison with control cells, and the combination of G-CSF, GM-CSF, and SCF increased survivin levels even further. Conversely, all-trans retinoic acid significantly decreased survivin protein levels in HL-60, OCI-AML3, and NB-4 cells within 96 hours, parallel to the induction of myelomonocytic differentiation. Using selective pharmacologic inhibitors, the differential involvement of mitogen-activated protein kinase kinase (MEK) and phosphatidylinositol-3 kinase (PI3K) pathways were demonstrated in the regulation of survivin expression. The MEK inhibitor PD98059 down-regulated survivin expression in both resting and GM-CSF-stimulated OCI-AML3 cells, whereas the PI3K inhibitor LY294002 inhibited survivin expression only on GM-CSF stimulation. In conclusion, these results demonstrate that survivin is highly expressed and cytokine-regulated in myeloid leukemias and suggest that hematopoietic cytokines exert their antiapoptotic and mitogenic effects, at least in part, by increasing survivin levels.
Similar articles
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.Blood. 2003 Jul 15;102(2):630-7. doi: 10.1182/blood-2002-06-1890. Epub 2003 Mar 27. Blood. 2003. PMID: 12663443
-
Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.Int J Hematol. 1998 Dec;68(4):387-401. doi: 10.1016/s0925-5710(98)00095-4. Int J Hematol. 1998. PMID: 9885438
-
Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.Blood. 1996 Nov 15;88(10):3987-97. Blood. 1996. PMID: 8916965
-
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
-
Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.Acta Haematol. 1996;95(3-4):257-62. doi: 10.1159/000203893. Acta Haematol. 1996. PMID: 8677752 Review.
Cited by
-
Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.PLoS One. 2012;7(10):e47668. doi: 10.1371/journal.pone.0047668. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082191 Free PMC article.
-
Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia Cells.Antioxidants (Basel). 2020 Jul 17;9(7):633. doi: 10.3390/antiox9070633. Antioxidants (Basel). 2020. PMID: 32709140 Free PMC article.
-
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.Ann Hematol. 2016 Dec;95(12):1931-1942. doi: 10.1007/s00277-016-2810-z. Epub 2016 Oct 3. Ann Hematol. 2016. PMID: 27696203 Free PMC article. Clinical Trial.
-
Intercellular network structure and regulatory motifs in the human hematopoietic system.Mol Syst Biol. 2014 Jul 15;10(7):741. doi: 10.15252/msb.20145141. Mol Syst Biol. 2014. PMID: 25028490 Free PMC article.
-
Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.Cancer Lett. 2015 Oct 1;366(2):160-72. doi: 10.1016/j.canlet.2015.05.033. Epub 2015 Jun 26. Cancer Lett. 2015. PMID: 26123662 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources